Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain.
Neuropharmacology. 2020 Nov 1;178:108226. doi: 10.1016/j.neuropharm.2020.108226. Epub 2020 Aug 6.
Neuropharmacology. 2020.
PMID: 32771527